Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Aberer

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Endocrinology|July 23, 2021
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled TrialOthmar Moser, Max L Eckstein, Alexander Mueller, et al.
European Journal of Nutrition|April 1, 2018
Effects of vitamin D supplementation on FGF23: a randomized-controlled trialChristian Trummer, Verena Schwetz, Marlene Pandis, et al.
Diabetes Technology & Therapeutics|September 11, 2015
Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different WardsKatharina M Neubauer, Julia K Mader, Bernhard Höll, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology]Harald Sourij, Felix Aberer, Marlies Antlanger, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2015
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trialStefan Pilz, Martin Gaksch, Katharina Kienreich, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysisOthmar Moser, Christoph Sternad, Max L Eckstein, et al.
Diabetes Care|December 1, 2021
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM StudyFelix Aberer, Othmar Moser, Faisal Aziz, et al.
Journal of Hypertension|April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trialAndreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Endocrinology|July 23, 2021
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled TrialOthmar Moser, Max L Eckstein, Alexander Mueller, et al.
European Journal of Nutrition|April 1, 2018
Effects of vitamin D supplementation on FGF23: a randomized-controlled trialChristian Trummer, Verena Schwetz, Marlene Pandis, et al.
Diabetes Technology & Therapeutics|September 11, 2015
Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different WardsKatharina M Neubauer, Julia K Mader, Bernhard Höll, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology]Harald Sourij, Felix Aberer, Marlies Antlanger, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2015
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trialStefan Pilz, Martin Gaksch, Katharina Kienreich, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysisOthmar Moser, Christoph Sternad, Max L Eckstein, et al.
Diabetes Care|December 1, 2021
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM StudyFelix Aberer, Othmar Moser, Faisal Aziz, et al.
Journal of Hypertension|April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trialAndreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Pageof 10